While Novo Nordisk maintains dominance through scale and innovation, Boehringer Ingelheim is demonstrating significant growth potential
Combined, they represent over 1.2 million patients in real-world clinical practice, and they both show that people taking GLP-1 medications develop fewer blood clots than comparable patients on other treatments
Eli Lilly, the innovator behind Retatrutide, is a world-renowned pharmaceutical company known for producing trusted medications like Trulicity, Zepbound, and Mounjaro
Vitamin D and calcium are critical for muscle contraction and bone health
In addition to greater weight loss, participants who took either dose of orforglipron recorded lower average blood sugar levels at the end of the trial than either dose of semaglutide
These warnings are particularly relevant in the context of injectable GLP-1 and related receptor agonists, a class that has seen a significant rise in falsified and substandard products circulating in the UK